Annual EBITDA
-$10.25 M
+$2.68 M+20.72%
December 31, 2023
Summary
- As of February 7, 2025, NDRA annual EBITDA is -$10.25 million, with the most recent change of +$2.68 million (+20.72%) on December 31, 2023.
- During the last 3 years, NDRA annual EBITDA has risen by +$1.08 million (+9.56%).
- NDRA annual EBITDA is now -588.11% below its all-time high of -$1.49 million, reached on December 31, 2014.
Performance
NDRA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$1.51 M
+$671.70 K+30.80%
September 30, 2024
Summary
- As of February 7, 2025, NDRA quarterly EBITDA is -$1.51 million, with the most recent change of +$671.70 thousand (+30.80%) on September 30, 2024.
- Over the past year, NDRA quarterly EBITDA has increased by +$1.55 million (+50.66%).
- NDRA quarterly EBITDA is now -408.59% below its all-time high of -$296.70 thousand, reached on December 31, 2016.
Performance
NDRA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$7.81 M
+$1.55 M+16.55%
September 30, 2024
Summary
- As of February 7, 2025, NDRA TTM EBITDA is -$7.81 million, with the most recent change of +$1.55 million (+16.55%) on September 30, 2024.
- Over the past year, NDRA TTM EBITDA has increased by +$4.28 million (+35.42%).
- NDRA TTM EBITDA is now -1333.23% below its all-time high of -$545.00 thousand, reached on September 30, 2015.
Performance
NDRA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
NDRA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.7% | +50.7% | +35.4% |
| 3 y3 years | +9.6% | +50.7% | +35.4% |
| 5 y5 years | -13.8% | +50.7% | +35.4% |
NDRA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +20.7% | -8.1% | +57.1% | at high | +39.9% |
| 5 y | 5-year | at high | +20.7% | -8.1% | +57.1% | at high | +39.9% |
| alltime | all time | -588.1% | +20.7% | -408.6% | +57.1% | -1333.2% | +39.9% |
ENDRA Life Sciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.51 M(-30.8%) | -$7.81 M(-16.6%) |
| Jun 2024 | - | -$2.18 M(-20.0%) | -$9.36 M(-7.3%) |
| Mar 2024 | - | -$2.72 M(+95.1%) | -$10.10 M(-1.4%) |
| Dec 2023 | -$10.25 M(-20.7%) | -$1.40 M(-54.3%) | -$10.25 M(-15.3%) |
| Sep 2023 | - | -$3.06 M(+4.7%) | -$12.09 M(-2.4%) |
| Jun 2023 | - | -$2.92 M(+1.9%) | -$12.39 M(-4.6%) |
| Mar 2023 | - | -$2.87 M(-11.6%) | -$12.99 M(+0.5%) |
| Dec 2022 | -$12.92 M(+14.6%) | -$3.25 M(-3.4%) | -$12.92 M(+1.8%) |
| Sep 2022 | - | -$3.36 M(-4.5%) | -$12.70 M(+6.5%) |
| Jun 2022 | - | -$3.52 M(+25.4%) | -$11.93 M(+3.3%) |
| Mar 2022 | - | -$2.80 M(-7.1%) | -$11.55 M(+2.4%) |
| Dec 2021 | -$11.27 M(-0.5%) | -$3.02 M(+16.6%) | -$11.27 M(+8.0%) |
| Sep 2021 | - | -$2.59 M(-17.5%) | -$10.44 M(-5.9%) |
| Jun 2021 | - | -$3.14 M(+24.3%) | -$11.09 M(+2.7%) |
| Mar 2021 | - | -$2.53 M(+15.9%) | -$10.80 M(-4.7%) |
| Dec 2020 | -$11.33 M(+4.5%) | -$2.18 M(-32.7%) | -$11.33 M(-7.7%) |
| Sep 2020 | - | -$3.24 M(+13.6%) | -$12.28 M(+4.9%) |
| Jun 2020 | - | -$2.85 M(-6.7%) | -$11.70 M(+4.8%) |
| Mar 2020 | - | -$3.06 M(-2.2%) | -$11.16 M(+3.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$10.84 M(+20.4%) | -$3.13 M(+17.3%) | -$10.84 M(+11.6%) |
| Sep 2019 | - | -$2.67 M(+15.2%) | -$9.71 M(+3.2%) |
| Jun 2019 | - | -$2.31 M(-15.2%) | -$9.41 M(+5.7%) |
| Mar 2019 | - | -$2.73 M(+36.5%) | -$8.90 M(-1.0%) |
| Dec 2018 | -$9.00 M(+97.1%) | -$2.00 M(-15.4%) | -$8.99 M(-3.0%) |
| Sep 2018 | - | -$2.36 M(+30.7%) | -$9.27 M(+18.8%) |
| Jun 2018 | - | -$1.81 M(-35.9%) | -$7.81 M(+10.9%) |
| Mar 2018 | - | -$2.82 M(+23.7%) | -$7.04 M(+54.3%) |
| Dec 2017 | -$4.56 M(+164.3%) | -$2.28 M(+154.7%) | -$4.56 M(+76.9%) |
| Sep 2017 | - | -$895.80 K(-14.0%) | -$2.58 M(+13.5%) |
| Jun 2017 | - | -$1.04 M(+201.9%) | -$2.27 M(+33.0%) |
| Mar 2017 | - | -$345.00 K(+16.3%) | -$1.71 M(-0.7%) |
| Dec 2016 | -$1.73 M(+15.4%) | -$296.70 K(-49.6%) | -$1.72 M(-7.6%) |
| Sep 2016 | - | -$588.80 K(+23.1%) | -$1.86 M(+2.4%) |
| Jun 2016 | - | -$478.20 K(+33.8%) | -$1.82 M(+35.7%) |
| Mar 2016 | - | -$357.30 K(-18.6%) | -$1.34 M(+36.3%) |
| Dec 2015 | -$1.50 M(+0.5%) | -$439.00 K(-19.4%) | -$984.00 K(+80.6%) |
| Sep 2015 | - | -$545.00 K | -$545.00 K |
| Dec 2014 | -$1.49 M | - | - |
FAQ
- What is ENDRA Life Sciences annual EBITDA?
- What is the all time high annual EBITDA for ENDRA Life Sciences?
- What is ENDRA Life Sciences annual EBITDA year-on-year change?
- What is ENDRA Life Sciences quarterly EBITDA?
- What is the all time high quarterly EBITDA for ENDRA Life Sciences?
- What is ENDRA Life Sciences quarterly EBITDA year-on-year change?
- What is ENDRA Life Sciences TTM EBITDA?
- What is the all time high TTM EBITDA for ENDRA Life Sciences?
- What is ENDRA Life Sciences TTM EBITDA year-on-year change?
What is ENDRA Life Sciences annual EBITDA?
The current annual EBITDA of NDRA is -$10.25 M
What is the all time high annual EBITDA for ENDRA Life Sciences?
ENDRA Life Sciences all-time high annual EBITDA is -$1.49 M
What is ENDRA Life Sciences annual EBITDA year-on-year change?
Over the past year, NDRA annual EBITDA has changed by +$2.68 M (+20.72%)
What is ENDRA Life Sciences quarterly EBITDA?
The current quarterly EBITDA of NDRA is -$1.51 M
What is the all time high quarterly EBITDA for ENDRA Life Sciences?
ENDRA Life Sciences all-time high quarterly EBITDA is -$296.70 K
What is ENDRA Life Sciences quarterly EBITDA year-on-year change?
Over the past year, NDRA quarterly EBITDA has changed by +$1.55 M (+50.66%)
What is ENDRA Life Sciences TTM EBITDA?
The current TTM EBITDA of NDRA is -$7.81 M
What is the all time high TTM EBITDA for ENDRA Life Sciences?
ENDRA Life Sciences all-time high TTM EBITDA is -$545.00 K
What is ENDRA Life Sciences TTM EBITDA year-on-year change?
Over the past year, NDRA TTM EBITDA has changed by +$4.28 M (+35.42%)